Literature DB >> 876703

Menkes' Kinky hair syndrome: studies of copper metabolism and long term copper therapy.

D M Williams, C L Atkin, D B Frens, P F Bray.   

Abstract

A patient with Menkes' kinky hair syndrome was treated with oral CuSO4. Plasma copper, ceruloplasmin, red cell copper, and 24-hr urine copper excretion remained essentially unchanged. Intravenous copper infusion resulted in a rise of serum ceruloplasmin. During administration of a test meal of 64Cu(NO3)2, the patient was given alternately a volume of 0.9% NaCl or an equal volume of plasma intravenously. Radioactivity found in the blood was unchanged after each infusion period. During 427 days of subcutaneous copper, plasma p-phenylenediamine oxidase activity and plasma copper rose toward normal. Subsequent balance studies showed that the patient was in negative copper balance because of large losses in feces. Scanning electron microscopy demonstrated persistent pili torti.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 876703     DOI: 10.1203/00006450-197707000-00009

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

Review 1.  Menkes disease: recent advances and new aspects.

Authors:  Z Tümer; N Horn
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  Menkes' disease: long-term treatment with copper and D-penicillamine.

Authors:  D Nadal; K Baerlocher
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

3.  Clinical and biochemical consequences of copper-histidine therapy in Menkes disease.

Authors:  J Kreuder; A Otten; H Fuder; Z Tümer; T Tønnesen; N Horn; D Dralle
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

Review 4.  [Trichopoliodystrophy or Menkes disease].

Authors:  O Dobrescu; A Larbrisseau; L J Dubé; M L Weber
Journal:  Can Med Assoc J       Date:  1980-09-20       Impact factor: 8.262

5.  Familial benign copper deficiency.

Authors:  K Méhes; E Petrovicz
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.